Intra-Cellular Therapies Inc. (ITCI): Price and Financial Metrics
Intra-Cellular Therapies Inc. (ITCI)
Today's Latest Price: $21.59 USD
0.22 (1.03%)
Updated Jun 5 4:00pm
Add ITCI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ITCI Stock Summary
- With a price/sales ratio of 1,253.98, Intra-Cellular Therapies Inc has a higher such ratio than 99.59% of stocks in our set.
- As for revenue growth, note that ITCI's revenue has grown 1,787.54% over the past 12 months; that beats the revenue growth of 99.54% of US companies in our set.
- In terms of volatility of its share price, ITCI is more volatile than 91.68% of stocks we're observing.
- Stocks that are quantitatively similar to ITCI, based on their financial statements, market capitalization, and price volatility, are TOCA, MRSN, CRMD, CBMG, and SCYX.
- ITCI's SEC filings can be seen here. And to visit Intra-Cellular Therapies Inc's official web site, go to www.intracellulartherapies.com.
ITCI Daily Price Range
ITCI 52-Week Price Range
ITCI Stock Price Chart More Charts
ITCI Price/Volume Stats
| Current price | $21.59 | 52-week high | $43.56 |
| Prev. close | $21.37 | 52-week low | $6.75 |
| Day low | $21.34 | Volume | 913,465 |
| Day high | $22.26 | Avg. volume | 1,150,660 |
| 50-day MA | $18.68 | Dividend yield | N/A |
| 200-day MA | $16.18 | Market Cap | 1.43B |
Intra-Cellular Therapies Inc. (ITCI) Company Bio
Intra-Cellular Therapies is developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases and diseases of the elderly, including Parkinson's and Alzheimer's disease. The company was founded in 2002 and is based in New York, New York.
Loading social stream, please wait...